Packaging GMP Audit Checklist

Pharma Packaging Site cGMP Onsite Audit Checklist

Updated: Jun 2025QTC Global Compliance TeamRegulatory reference content

Providing a GMP audit checklist for packaging facilities (plastics, glass, rubber), covering cleanroom classification, mix-up prevention, and lot traces.

Key answer

When drug manufacturers audit packaging suppliers, the focus is on preventing secondary contamination and mix-ups. Key items include: cleanroom grades for extrusion/blowing/injection molding (direct-contact packagings, like sterile syringe barrels, must be molded in Grade C+A or D rooms); strict line clearance in printing and labeling zones; and traceable batch records linking raw resin lots, molding parameters, and final release tests.

Three Key Inspection Checkpoints on Packaging Sites

Auditors evaluate physical flow and engineering guards on the production floor to verify separation boundaries.

  • Release agents: mold release lubricants used in molding must be pharmacopeially safe, with restricted usage
  • Line clearance: documenting 100% clean-out of hoppers and conveyors when transitioning between bottle configurations
  • Particulates: vacuum/static dust removal systems operation, preventing plastic burs from contaminating final seals

FAQ

What cleanroom grade is required for primary packaging sites?+

It depends on intended drug use. Final molding and packaging of sterile components (vials, syringe plungers) are recommended in ISO 8 (Grade D) or ISO 7 (Grade C) cleanrooms. Bottles for dry oral tablets can be made in controlled, non-classified spaces but require surface microbial testing.

Next steps

If this topic applies to your product, facility, or supply chain requirement, start by confirming the target market, customer-required standard, existing documents, audit history, and expected timeline.